Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Molecular Transport Inc (NQ: AMTI )

0.6399 +0.0299 (+4.90%)
Streaming Delayed Price Updated: 12:23 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,121
Open 0.6500
Bid (Size) 0.6300 (5)
Ask (Size) 0.6399 (1)
Prev. Close 0.6100
Today's Range 0.6151 - 0.6579
52wk Range 0.3299 - 10.42
Shares Outstanding 38,943,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Applied Molecular Transport To $2? Here Are Other Price Target Changes For Tuesday
 
Via Benzinga

Performance

YTD
+33.51%
+33.51%
1 Month
+33.51%
+33.51%
3 Month
-20.65%
-20.65%
6 Month
-63.85%
-63.85%
1 Year
-93.21%
-93.21%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
What To Know About SVB Leerink's Downgrade of Applied Molecular
Via Benzinga
Dow Rises 150 Points; Mission Produce Shares Slide
Via Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Applied Molecular's Ulcerative Colitis Candidate Fails To Separate From Placebo In Untreated Patients
Via Benzinga
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
From Applied Molecular Transport Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of Pouchitis
From Applied Molecular Transport Inc.
Via Globe NewsWire
Applied Molecular Transport to Present at Upcoming November Investor Conferences
From Applied Molecular Transport Inc.
Via Globe NewsWire
Applied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Applied Molecular Transport Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.